These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9093190)

  • 21. Long-term administration of gonadotropin-releasing hormone agonist and dexamethasone: assessment of the adrenal role in ovarian dysfunction.
    Cedars MI; Steingold KA; de Ziegler D; Lapolt PS; Chang RJ; Judd HL
    Fertil Steril; 1992 Mar; 57(3):495-500. PubMed ID: 1531463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of buserelin testing in the evaluation of hirsute women.
    Ambrosi B; Re T; Passini E; Bochicchio D; Ferrario R
    J Endocrinol Invest; 1996 Apr; 19(4):204-9. PubMed ID: 8862498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the ovary in the adrenal androgen excess of hyperandrogenic women.
    Azziz R; Rittmaster RS; Fox LM; Bradley EL; Potter HD; Boots LR
    Fertil Steril; 1998 May; 69(5):851-9. PubMed ID: 9591492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
    Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
    Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy.
    Valentino R; Tommaselli AP; Savastano S; Dorato M; Rossi R; Lombardi G
    Fertil Steril; 1997 Aug; 68(2):236-41. PubMed ID: 9240249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Source localization of androgen excess in adolescent girls.
    Ibáñez L; Potau N; Zampolli M; Prat N; Gussinyé M; Saenger P; Vicens-Calvet E; Carrascosa A
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women.
    Allen SE; Potter HD; Azziz R
    Fertil Steril; 1997 Mar; 67(3):569-72. PubMed ID: 9091350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
    Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Critical study of the characterization of hyperandrogenism in a group of obese women].
    Cordray JP; Merceron RE; Nys P; Guillerd X; Reboul P; Rainaut M
    Rev Fr Gynecol Obstet; 1995 Oct; 90(10):403-8. PubMed ID: 8539505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome.
    Carmina E; Gonzalez F; Vidali A; Stanczyk FZ; Ferin M; Lobo RA
    Hum Reprod; 1999 Feb; 14(2):307-11. PubMed ID: 10099969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian and adrenal hyperandrogenism.
    Carmina E
    Ann N Y Acad Sci; 2006 Dec; 1092():130-7. PubMed ID: 17308139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings.
    Moltz L; Schwartz U; Sörensen R; Pickartz H; Hammerstein J
    Fertil Steril; 1984 Jul; 42(1):69-75. PubMed ID: 6233180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Polycystic ovary syndrome of extra-ovarian origin. Review].
    Terán Dávila J; Teppa-Garrán AD
    Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal steroidogenesis is related to insulin in hyperandrogenic women.
    Martikainen H; Salmela P; Nuojua-Huttunen S; Perälä J; Leinonen S; Knip M; Ruokonen A
    Fertil Steril; 1996 Oct; 66(4):564-70. PubMed ID: 8816617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
    J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.